HTRA1 and breast carcinoma: Depressed levels of HTRA1 are correlated with more aggressive forms of breast cancers characterized by nodal metastasis, estrogen receptor downregulation, high-grade tumors exhibiting p53 point mutations, lymphocytic infiltration [31], and reduced disease-free survival [29,31].